最近搜索:細胞培養 微生物學 分子生物 生物化學
    首頁>>免疫學>>一抗>>骨保護蛋白配體/破骨細胞分化因子抗體
    骨保護蛋白配體/破骨細胞分化因子抗體
    • 產品貨號:
      BN41584R
    • 中文名稱:
      骨保護蛋白配體/破骨細胞分化因子抗體
    • 英文名稱:
      Rabbit anti-RANKL/CD254 Polyclonal antibody
    • 品牌:
      Biorigin
    • 貨號

      產品規格

      售價

      備注

    • BN41584R-50ul

      50ul

      ¥1486.00

      交叉反應:Human,Mouse(predicted:Rat,Dog) 推薦應用:WB,IHC-P,IHC-F,IF,Flow-Cyt,ELISA

    • BN41584R-100ul

      100ul

      ¥2360.00

      交叉反應:Human,Mouse(predicted:Rat,Dog) 推薦應用:WB,IHC-P,IHC-F,IF,Flow-Cyt,ELISA

    • BN41584R-200ul

      200ul

      ¥3490.00

      交叉反應:Human,Mouse(predicted:Rat,Dog) 推薦應用:WB,IHC-P,IHC-F,IF,Flow-Cyt,ELISA

    產品描述

    英文名稱RANKL/CD254
    中文名稱骨保護蛋白配體/破骨細胞分化因子抗體
    別    名OPGL; CD254; hRANKL2; ODF; OPGL; Osteoclast differentiation factor; Osteoprotegerin ligand; RANKL; Receptor activator of nuclear factor kappa B ligand; sOdf; SOFA; TNF related activation induced cytokine; TNFSF 11; TNFSF11; TRANCE; Tumor necrosis factor ligand superfamily member 11; Osteoprotegerin Ligand; TNF11_HUMAN. 



    研究領域腫瘤  細胞生物  免疫學  發育生物學  
    抗體來源Rabbit
    克隆類型Polyclonal
    交叉反應Human, Mouse,  (predicted: Rat, Dog, )
    產品應用WB=1:500-2000 ELISA=1:5000-10000 IHC-P=1:100-500 IHC-F=1:100-500 Flow-Cyt=1μg/Test  IF=1:100-500 (石蠟切片需做抗原修復)
    not yet tested in other applications.
    optimal dilutions/concentrations should be determined by the end user.
    分 子 量35kDa
    細胞定位細胞漿 細胞膜 分泌型蛋白 
    性    狀Liquid
    濃    度1mg/ml
    免 疫 原KLH conjugated synthetic peptide derived from human OPGL:210-317/317 
    亞    型IgG
    純化方法affinity purified by Protein A
    儲 存 液0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
    保存條件Shipped at 4℃. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles.
    PubMedPubMed
    產品介紹This gene encodes a member of the tumor necrosis factor (TNF) cytokine family which is a ligand for osteoprotegerin and functions as a key factor for osteoclast differentiation and activation. This protein was shown to be a dentritic cell survival factor and is involved in the regulation of T cell-dependent immune response. T cell activation was reported to induce expression of this gene and lead to an increase of osteoclastogenesis and bone loss. This protein was shown to activate antiapoptotic kinase AKT/PKB through a signaling complex involving SRC kinase and tumor necrosis factor receptor-associated factor (TRAF) 6, which indicated this protein may have a role in the regulation of cell apoptosis. Targeted disruption of the related gene in mice led to severe osteopetrosis and a lack of osteoclasts. The deficient mice exhibited defects in early differentiation of T and B lymphocytes, and failed to form lobulo-alveolar mammary structures during pregnancy. Two alternatively spliced transcript variants have been found. [provided by RefSeq, Jul 2008].

    Function:
    Cytokine that binds to TNFRSF11B/OPG and to TNFRSF11A/RANK. Osteoclast differentiation and activation factor. Augments the ability of dendritic cells to stimulate naive T-cell proliferation. May be an important regulator of interactions between T-cells and dendritic cells and may play a role in the regulation of the T-cell-dependent immune response. May also play an important role in enhanced bone-resorption in humoral hypercalcemia of malignancy.

    Subcellular Location:
    Cytoplasm; Secreted and Cell membrane.

    Tissue Specificity:
    Highest in the peripheral lymph nodes, weak in spleen, peripheral blood Leukocytes, bone marrow, heart, placenta, skeletal muscle, stomach and thyroid.

    Post-translational modifications:
    The soluble form of isoform 1 derives from the membrane form by proteolytic processing. The cleavage may be catalyzed by ADAM17.

    DISEASE:
    Defects in TNFSF11 are the cause of osteopetrosis autosomal recessive type 2 (OPTB2) [MIM:259710]; also known as osteoclast-poor osteopetrosis. Osteopetrosis is a rare genetic disease characterized by abnormally dense bone, due to defective resorption of immature bone. The disorder occurs in two forms: a severe autosomal recessive form occurring in utero, infancy, or childhood, and a benign autosomal dominant form occurring in adolescence or adulthood. Autosomal recessive osteopetrosis is usually associated with normal or elevated amount of non-functional osteoclasts. OPTB2 is characterized by paucity of osteoclasts, suggesting a molecular defect in osteoclast development.

    Similarity:
    Belongs to the tumor necrosis factor family.

    SWISS:
    O14788

    Gene ID:
    8600

    Database links:

    Entrez Gene: 8600 Human

    Entrez Gene: 21943 Mouse

    Omim: 602642 Human

    SwissProt: O14788 Human

    SwissProt: O35235 Mouse

    Unigene: 333791 Human

    Unigene: 249221 Mouse



    Important Note:
    This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.

    OPGL骨保護蛋白配體又稱骨保護素配體(破骨細胞發育刺激因子)。屬腫瘤壞死因子TNF-a家族。
    OPGL促進破骨細胞的分化和活性,而OPG抑制這些過程。骨髓瘤細胞影響骨髓中這兩種蛋白的生理平衡,是發生溶骨性病變的根本所在。


    亚洲精品无码专区久久同性男| 亚洲国产美国国产综合一区二区| 亚洲午夜日韩高清一区| 久久亚洲精品专区蓝色区| 亚洲高清国产拍精品26U| 亚洲?v女人的天堂在线观看| 亚洲人成在久久综合网站| 亚洲国产精彩中文乱码AV| 国产AⅤ无码专区亚洲AV| 亚洲精品tv久久久久| 亚洲精品成人区在线观看| 亚洲成a人片在线播放| 亚洲国产婷婷香蕉久久久久久| 亚洲精品国产高清嫩草影院| 亚洲AV无码一区二区三区国产| 亚洲A∨午夜成人片精品网站| 亚洲AV无码之日韩精品| 亚洲成av人片一区二区三区| 亚洲国产成人久久一区WWW| 亚洲精品在线视频| 一本久久a久久精品亚洲| 亚洲乱色熟女一区二区三区丝袜 | 亚洲精品免费在线| 亚洲视频在线不卡| 亚洲精品亚洲人成在线观看麻豆 | 亚洲天堂中文资源| 亚洲高清日韩精品第一区 | 豆国产96在线|亚洲| 国产亚洲漂亮白嫩美女在线 | 亚洲日韩在线中文字幕综合| 小说专区亚洲春色校园| 亚洲国产91精品无码专区| 亚洲人成电影在线播放| 国产亚洲午夜高清国产拍精品| 狠狠亚洲婷婷综合色香五月排名| 亚洲色精品88色婷婷七月丁香 | 在线观看亚洲AV日韩AV| 亚洲AV日韩综合一区| 亚洲视频在线精品| 亚洲不卡中文字幕无码| 亚洲黄色高清视频|